SCHEMBL29670375

SCHEMBL29670375

OCc1cnc(-c2ccccc2F)s1

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.42
ALDH1A1 P00352 2/20 0.42
NPC1 O15118 5/20 0.41
HSD17B13 Q7Z5P4 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.37
CASP3 P42574 1/20 0.37
SENP8 Q96LD8 1/20 0.37
SENP7 Q9BQF6 1/20 0.37
SENP6 Q9GZR1 1/20 0.37
RAB9A P51151 3/20 0.37
RXFP1 Q9HBX9 1/20 0.37
SRC P12931 1/20 0.36
ZAP70 P43403 1/20 0.36
SYK P43405 1/20 0.36
CYP11B1 P15538 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
CYP11B2 P19099 1/20 0.36
HIF1A Q16665 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18975047 1.00 KDM4E (0.42) KDM4EALDH1A1NPC1HSD17B13L3MBTL1
SCHEMBL15356501 0.83 KDM4E (0.42) KDM4EALDH1A1NPC1HSD17B13L3MBTL1
SCHEMBL23146244 0.81 SRC (0.41) KDM4EALDH1A1NPC1HSD17B13L3MBTL1
SCHEMBL3436688 0.78 KDM4E (0.48) KDM4EALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL1895825 0.77 CYP11B1 (0.56) KDM4EALDH1A1NPC1RAB9ACYP11B1
SCHEMBL5539232 0.75 KDM4E (0.42) KDM4EALDH1A1NPC1HSD17B13RAB9A
SCHEMBL18975046 0.74 PTPN11 (0.43) KDM4EALDH1A1NPC1RAB9ASRC
SCHEMBL20539648 0.73 HSD17B13 (0.42) HSD17B13SRCZAP70SYKCYP11B1
SCHEMBL2095244 0.73 KDM4E (0.46) KDM4EALDH1A1NPC1RAB9A
SCHEMBL2095243 0.73 KDM4E (0.46) KDM4EALDH1A1NPC1L3MBTL1CASP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114746089-A Thiazolecarboxamide compounds and their use for the treatment of mycobacterial infections 结核病药物开发全球联盟公司 2022-07-12 CN disclosed